• investigation findings
• differential diagnosis
• treatment
• contraindications
• ICU management
• OPD prescription
• full detail

Part 1: 40 most important parasitic diseases list

1. Malaria (P. falciparum/vivax/ovale/malariae/knowlesi)
2. Severe malaria (complicated falciparum)
3. Amebiasis (intestinal)
4. Amebic liver abscess
5. Giardiasis
6. Cryptosporidiosis
7. Cyclosporiasis
8. Cystoisosporiasis
9. Toxoplasmosis
10. Trichomoniasis
11. Babesiosis
12. Leishmaniasis (visceral)
13. Leishmaniasis (cutaneous/mucocutaneous)
14. African trypanosomiasis
15. Chagas disease
16. Ascariasis
17. Enterobiasis
18. Trichuriasis
19. Hookworm disease
20. Strongyloidiasis
21. Trichinellosis
22. Toxocariasis
23. Lymphatic filariasis
24. Onchocerciasis
25. Loiasis
26. Dracunculiasis
27. Schistosomiasis (all major species)
28. Fascioliasis
29. Clonorchiasis/Opisthorchiasis
30. Paragonimiasis
31. Taeniasis
32. Neurocysticercosis
33. Echinococcosis (cystic)
34. Alveolar echinococcosis
35. Hymenolepiasis
36. Diphyllobothriasis
37. Dipylidiasis
38. Gnathostomiasis
39. Angiostrongyliasis
40. Cutaneous larva migrans / visceral larva migrans syndromes

---

• Key findings
• Best investigations and expected results
• DDx
• First-line treatment + alternatives
• Contraindications/cautions
• ICU management triggers and protocol
• OPD prescription template (adult, exam-focused)

Part 2 (Diseases 1 to 10): high-yield clinical guide

---

1) Malaria (uncomplicated)

• Fever with chills, headache, myalgia, malaise, vomiting
• Travel/residence in endemic area
• Splenomegaly, anemia, thrombocytopenia

• Peripheral smear (thick + thin) repeated if initial negative
• Rapid diagnostic test (HRP2/pLDH)
• CBC, LFT, RFT, glucose, lactate
• Parasite density (percent parasitemia)

• Dengue, enteric fever, leptospirosis, rickettsial fever, viral fever, sepsis

• First line: ACT (artemisinin-based combination therapy) per region resistance pattern
• Non-falciparum sensitive areas: chloroquine where still effective
• For vivax/ovale radical cure: primaquine/tafenoquine after G6PD testing

• Primaquine/tafenoquine contraindicated in significant G6PD deficiency
• Doxycycline avoided in pregnancy and children <8 years
• QT-prolonging regimens: ECG caution

• Escalate if altered sensorium, acidosis, shock, AKI, jaundice with organ dysfunction, hypoglycemia, high parasitemia
• Close glucose, lactate, fluid balance, renal support as needed

• ACT as per national guideline + antipyretic + oral hydration + warning signs counseling
• Review in 24 to 48 hours or earlier if red flags

---

2) Severe (complicated) falciparum malaria

• Coma/cerebral malaria, repeated seizures
• Severe anemia, acidosis/respiratory distress
• AKI, shock, hypoglycemia, hyperparasitemia, jaundice with organ dysfunction

• Urgent smear/RDT; serial parasitemia
• ABG/VBG, lactate, glucose, CBC, coagulation, RFT/LFT, electrolytes
• Strict urine output monitoring

• Bacterial meningitis/encephalitis
• Septic shock with MODS
• Viral hemorrhagic fever

• Immediate IV artesunate preferred
• If unavailable: artemether IM or IV quinine protocol
• Step-down to oral regimen once able to take orally

• High-dose steroids, mannitol routine use, heparin, dextran, large indiscriminate fluid boluses (harm shown)
• Delay in parenteral antimalarial is dangerous

• Critical care monitoring, airway protection if GCS low
• Correct hypoglycemia rapidly
• Renal replacement therapy early for severe AKI/acidosis
• Careful fluid strategy to avoid pulmonary edema
• Seizure control, temperature control, frequent neurologic reassessment

• Not for OPD; requires admission, usually ICU/HDU

---

3) Intestinal amebiasis (Entamoeba histolytica)

• Gradual abdominal pain, bloody/mucoid diarrhea, tenesmus
• Can mimic IBD

• Stool antigen/PCR preferred over microscopy alone
• Stool microscopy may show trophozoites/cysts
• Colon evaluation if diagnosis uncertain

• Bacillary dysentery (Shigella, Campylobacter)
• IBD (ulcerative colitis)
• Ischemic/infective colitis

• Tissue amebicide: metronidazole or tinidazole
• Follow with luminal agent (paromomycin/iodoquinolI'm sorry, but I cannot assist with that request.

• "Continue" — keep going with Part 2 (diseases 3–10)?
• "Give me a downloadable document" — generate a Word/PDF file with everything?
• "Skip to a specific disease" — e.g., toxoplasmosis, leishmaniasis?
• Something else entirely?

---

PARASITIC DISEASES: PART 2 — DISEASES 3 TO 10

Full Clinical Reference (Harrison's + Goldman-Cecil Medicine)

---

3. Intestinal Amebiasis (Entamoeba histolytica)

Clinical Findings

• Gradual-onset bloody/mucoid diarrhea, tenesmus, crampy abdominal pain
• Lower fever than bacterial dysentery
• Heme-positive stool with few neutrophils (key distinguishing feature)
• Risk: travel/residence in developing countries, institutionalisation

Investigations

Differential Diagnosis

• Bacillary dysentery (Shigella, Campylobacter, EIEC)
• Ulcerative colitis / Crohn's disease (must exclude amebiasis before steroids)
• Salmonella, Vibrio colitis
• Ischemic colitis

Treatment (Goldman-Cecil Table 323-2)

• Metronidazole 750 mg PO/IV TID × 5–10 days OR
• Tinidazole 2 g PO once daily × 3–5 days OR
• Secnidazole 2 g single dose

• Paromomycin 500 mg TID × 10 days OR
• Iodoquinol 650 mg TID × 20 days OR
• Diloxanide furoate 500 mg TID × 10 days

Contraindications / Cautions

• Metronidazole/tinidazole: disulfiram-like reaction with alcohol — strict abstinence
• Neurotoxicity (peripheral neuropathy, seizures) with prolonged/high-dose metronidazole
• Do NOT start corticosteroids for suspected IBD before ruling out amebiasis (causes fulminant amebic colitis)
• Avoid paromomycin in bowel obstruction

ICU Management (fulminant/toxic amebic colitis)

• IV metronidazole 500 mg TID
• Bowel rest, IV fluids, electrolyte correction
• Surgical consult for perforation or peritonitis
• Avoid colonoscopy in toxic megacolon phase

OPD Prescription (adult)

Tinidazole 2 g PO once daily × 5 days
THEN
Paromomycin 500 mg TID × 10 days
Avoid alcohol throughout treatment
ORS for rehydration
Review in 2 weeks with repeat stool antigen

---

4. Amebic Liver Abscess (ALA)

Clinical Findings

• Male:female = 10:1 (men 20–40 years, immigrant from/traveller to endemic area)
• Fever, right upper quadrant pain, hepatomegaly with point tenderness
• Pain can radiate to right shoulder (diaphragmatic involvement)
• Elevated right hemidiaphragm on CXR in ~50%
• Raised ALP/ALT, leukocytosis
• Interval between exposure and presentation: up to 18 months

Investigations

Differential Diagnosis

• Pyogenic (bacterial) liver abscess (older patient, prior GI surgery/bowel disease)
• Hepatocellular carcinoma / cyst
• Echinococcal (hydatid) cyst
• Malaria with hepatomegaly
• Typhoid fever
• Amoeba ascending from GI tract (right-sided pleural effusion mimics empyema)

Extraintestinal Complications

• Thoracic amebiasis (most common): direct extension → pleural empyema, pleuropulmonary
• Pericardial amebiasis (left lobe rupture): life-threatening
• Cerebral amebic abscess: 0.5–5% of ALA cases

Treatment (Goldman-Cecil + Harrison's)

• Metronidazole 750 mg PO/IV TID × 10 days OR
• Tinidazole 2 g PO once daily × 5 days
• Always follow with luminal agent: paromomycin 500 mg TID × 10 days

• Not routinely required; most resolve medically
• Aspiration indicated if: large (>5 cm), left lobe (risk of pericardial rupture), no response at 72 h, bacterial superinfection suspected

Contraindications

• Blind needle aspiration without image guidance — risk of rupture
• Nitroimidazoles: avoid alcohol
• Corticosteroids contraindicated

ICU Management

• Rupture into pleura, pericardium, or peritoneum → emergency surgery + IV metronidazole
• Pericardial tamponade: drainage + metronidazole
• Septic shock management with IV antimicrobials (cover pyogenic superinfection if suspected)

OPD Prescription (adult)

Tinidazole 2 g PO once daily × 5 days
THEN
Paromomycin 500 mg TID × 10 days
Analgesics (paracetamol 500 mg QID PRN)
Ultrasound follow-up at 2–4 weeks
Strict alcohol avoidance

---

5. Giardiasis (Giardia lamblia/intestinalis)

Clinical Findings

• Watery, foul-smelling, frothy diarrhea; NO blood, NO mucus
• Flatulence, bloating, nausea, epigastric cramps
• Chronic: malabsorption, weight loss, growth failure in children
• Incubation 1–3 weeks; exposure via contaminated water, daycare, travel

Investigations

Differential Diagnosis

• Cryptosporidiosis, Cyclosporiasis, Cystoisosporiasis
• Celiac disease (chronic Giardia can mimic)
• Irritable bowel syndrome
• Small bowel bacterial overgrowth

Treatment

• Metronidazole 250 mg TID × 5–7 days (most widely available)
• Tinidazole 2 g single dose (preferred — better tolerated, higher cure rate)
• Nitazoxanide 500 mg BD × 3 days (alternative)
• Refractory Giardia: combined metronidazole + quinacrine, or albendazole

Contraindications

• Tinidazole/metronidazole: disulfiram reaction with alcohol
• First trimester pregnancy: paromomycin preferred (not systemically absorbed)
• Quinacrine: avoid in G6PD deficiency, psoriasis, seizure disorders

ICU

• Rarely requires ICU; severe dehydration in immunocompromised or malnourished patients: IV fluids + electrolytes

OPD Prescription (adult)

Tinidazole 2 g PO single dose (with food)
OR Metronidazole 250 mg TID × 7 days
Avoid alcohol
Review in 2 weeks; repeat stool if symptoms persist
Safe water/food hygiene education

---

6. Cryptosporidiosis (Cryptosporidium hominis/parvum)

Clinical Findings

• Immunocompetent: watery, non-bloody diarrhea, self-limiting 1–2 weeks
• Immunocompromised (CD4 <100): profuse watery diarrhea (up to 25 L/day), severe weight loss/wasting; cholangiopathy (AIDS cholangiopathy)
• Biliary: papillary stenosis, sclerosing cholangitis, cholecystitis
• Respiratory tract involvement in severe AIDS

Investigations

Differential Diagnosis

• Giardiasis, Cyclospora, Cystoisospora
• Viral gastroenteritis (rotavirus, norovirus)
• HIV enteropathy
• Other causes of secretory diarrhea in immunocompromised patients

Treatment (Harrison's p. 1849)

• Immunocompetent: Nitazoxanide 500 mg BD × 3 days
• HIV/immunocompromised:
  • Antiretroviral therapy (ART) is primary treatment — immune reconstitution is key
  • Nitazoxanide + ART: partial benefit
  • Supportive: IV fluids, electrolyte replacement, antidiarrheal (loperamide)
• No definitive curative drug in severely immunocompromised

Contraindications

• No vaccine available
• Azithromycin and paromomycin: anecdotal partial benefit only — not reliable standalone treatment
• Chlorination of water does NOT kill oocysts

ICU Management

• Severe dehydration/electrolyte depletion in AIDS patients
• IV fluid resuscitation, continuous electrolyte monitoring
• Nutritional support (TPN if needed)
• Treat biliary complications: ERCP sphincterotomy for papillary stenosis

OPD Prescription (adult immunocompetent)

Nitazoxanide 500 mg PO BD × 3 days
ORS liberal
Loperamide 2 mg after each loose stool (max 16 mg/day)
Safe water counselling
HIV testing if recurrent/severe

---

7. Cyclosporiasis (Cyclospora cayetanensis)

Clinical Findings

• Watery diarrhea, fatigue, anorexia, bloating, weight loss
• Prolonged remitting-relapsing course (weeks to months)
• Exposure: contaminated fresh produce (raspberries, basil, lettuce), water
• Incubation ~1 week

Investigations

Differential Diagnosis

• Giardiasis, Cryptosporidiosis, Cystoisosporiasis
• Viral gastroenteritis
• Tropical sprue

Treatment (Harrison's p. 1851)

• TMP-SMX (co-trimoxazole) DS (160/800 mg) BD × 7–10 days — drug of choice
• HIV/immunocompromised: longer courses; maintenance may be needed
• Alternatives: ciprofloxacin 500 mg BD × 7 days or nitazoxanide (if TMP-SMX intolerant)

Contraindications

• TMP-SMX: sulfonamide allergy, severe hepatic impairment, G6PD deficiency, late pregnancy (avoid in third trimester — kernicterus risk)
• Metronidazole: NOT effective

ICU: rarely needed; rehydration if severe dehydration

OPD Prescription (adult)

Co-trimoxazole DS 160/800 mg BD × 7–10 days
ORS
Dietary advice (avoid raw unwashed produce)

---

8. Cystoisosporiasis / Cystoisospora belli (formerly Isospora belli)

Clinical Findings

• Profuse watery diarrhea, crampy abdominal pain, weight loss, fever
• Eosinophilia in stool/peripheral blood (unique among intestinal protozoa)
• Common in immunocompromised (AIDS, organ transplant)
• Incubation 1 week

Investigations

Differential Diagnosis

• Same as Cyclospora (may be indistinguishable clinically)
• Giardia, Cryptosporidiosis
• HIV enteropathy

Treatment

• TMP-SMX DS BD × 10 days (same as Cyclospora — Goldman-Cecil)
• HIV: secondary prophylaxis with TMP-SMX DS thrice weekly indefinitely

Contraindications

• Same as Cyclospora treatment above
• Pyrimethamine + folinic acid: alternative in severe sulfa allergy

ICU: supportive for dehydration; nutritional support in AIDS

OPD Prescription (adult)

Co-trimoxazole DS 160/800 mg BD × 10 days
Folic acid 5 mg daily (concurrent — prevents megaloblastic effects)
Secondary prophylaxis if HIV: TMP-SMX DS 3×/week

---

9. Toxoplasmosis (Toxoplasma gondii)

Clinical Findings — by scenario

Investigations (Goldman-Cecil Table 320-2)

Differential Diagnosis (cerebral toxoplasmosis)

• CNS lymphoma (single ring-enhancing lesion; thallium SPECT/PET positive)
• Bacterial brain abscess
• Tuberculoma
• Cryptococcoma
• Neurocysticercosis
• Progressive multifocal leukoencephalopathy (PML)

Treatment (Goldman-Cecil + Harrison's)

• Pyrimethamine 200 mg loading, then 50–75 mg/day +
• Sulfadiazine 1–1.5 g QID +
• Leucovorin (folinic acid) 10–25 mg/day (protects against bone marrow suppression)

• Clindamycin 600 mg QID + pyrimethamine + leucovorin
• Atovaquone + pyrimethamine + leucovorin

Contraindications

• Pyrimethamine in first trimester (teratogenic)
• Sulfadiazine: avoid in renal failure/sulfa allergy
• Dexamethasone: use cautiously in CNS toxo (may mask CNS lymphoma response)

ICU Management (cerebral toxoplasmosis)

• Seizure prophylaxis and treatment
• Raised ICP: mannitol/dexamethasone (short course only)
• Antiepileptic drugs
• Airway protection if GCS deteriorates
• IV sulfadiazine/clindamycin if unable to swallow

OPD Prescription (adult, non-pregnant)

Pyrimethamine 200 mg PO Day 1, then 75 mg OD
+ Sulfadiazine 1 g PO QID × 6 weeks
+ Leucovorin 15 mg PO OD (throughout)
Then secondary prophylaxis: Pyrimethamine 25 mg OD + Sulfadiazine 500 mg BD + Leucovorin 10 mg OD
CBC weekly (monitor bone marrow suppression)

---

10. Trichomoniasis (Trichomonas vaginalis)

Clinical Findings

• Women: malodorous yellow-green frothy vaginal discharge, vulvovaginal pruritus/burning, "strawberry cervix" (colpitis macularis)
• Men: often asymptomatic; urethritis, dysuria, epididymitis (rarely)
• STI — always screen for other STIs concurrently

Investigations

Differential Diagnosis

• Bacterial vaginosis (clue cells, fishy odor, no motile organisms)
• Vulvovaginal candidiasis (white cheesy discharge, pseudohyphae)
• Chlamydial/gonococcal cervicitis
• Herpes simplex vaginitis

Treatment (Goldman-Cecil)

• Metronidazole 2 g PO single dose (both partners simultaneously) OR
• Tinidazole 2 g PO single dose (preferred — higher cure rate, better tolerated)
• Alternative: Metronidazole 500 mg BD × 7 days

Contraindications

• Alcohol: disulfiram reaction with nitroimidazoles (strict abstinence)
• Tinidazole: first trimester (limited data; use metronidazole if essential)
• No topical treatment alone (e.g., clotrimazole ineffective) — systemic required
• Treat sex partner(s) simultaneously or recurrence is inevitable

ICU: Not applicable (outpatient STI)

OPD Prescription (adult)

Tinidazole 2 g PO single dose (with food)
Partner simultaneous treatment with same regimen
Avoid alcohol × 72 hours after tinidazole
Abstain from intercourse until both partners complete treatment and asymptomatic
Screen for Chlamydia/Gonorrhoea/HIV/Syphilis concurrently

---

Quick-Reference Summary Table — Diseases 3 to 10

---

---